US Edition
Multiple Sclerosis: Women of Childbearing Age Receive Disease-Modifying Therapies Less Frequently – Deutsches Ärzteblatt
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lyon – Women aged 18-40 – i.e., those of childbearing age – are less likely than men to receive disease-modifying drugs (DMTs) to treat multiple sclerosis (MS). This applies even to therapies with proven safety during pregnancy or with sustained effects after discontinuation before conception. This is shown by a...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
